| 05th week of 2018 patent applcation highlights part 24 |
| Patent application number | Title | Published |
|---|
| 20180030035 | AMINOMETHYLENE PYRAZOLONES WITH THERAPEUTIC ACTIVITY | 2018-02-01 |
| 20180030036 | Factor IXa Inhibitors | 2018-02-01 |
| 20180030037 | HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS | 2018-02-01 |
| 20180030038 | Polymorphic Forms of Afatinib Dimaleate | 2018-02-01 |
| 20180030039 | PYRAZOLYL SUBSTITUTED CARBONIC ACID DERIVATIVES AS MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | 2018-02-01 |
| 20180030040 | SELECTIVE HDAC1 AND HDAC2 INHIBITORS | 2018-02-01 |
| 20180030041 | CONDENSATION PRODUCT OF 1-AMINO-2-PROPANOL AND FORMALDEHYDE AND THE USE THEREOF FOR REDUCING THE AMOUNT OF HYDROGEN SULPHIDE IN LIQUIDS AND GASES | 2018-02-01 |
| 20180030042 | Methods, Compounds, and Compositions for the Treatment of Angiotensin-Related Diseases | 2018-02-01 |
| 20180030043 | NOVEL PROCESS FOR THE PREPARATION OF 1,3-THIAZOL-5-YLMETHYL [(2R,5R)-5- CARBAMOYL) AMINO] -4-(MORPHOLIN-4-YL)BUTANOYL]AMINO}-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE | 2018-02-01 |
| 20180030044 | SELECTIVE BACE1 INHIBITORS | 2018-02-01 |
| 20180030045 | SELECTIVELY SUBSTITUTED QUINOLINE COMPOUNDS | 2018-02-01 |
| 20180030046 | NOVEL COMPOUNDS AND METHODS OF TREATING OR AMELIORATING AN IL-1R-MEDIATED DISEASE OR DISORDER USING SAME | 2018-02-01 |
| 20180030047 | COMPOUNDS FOR THEIR USE AS DRUGS FOR THE TREATMENT AND/OR THE PREVENTION OF INFECTION(S) CAUSED BY BIOFILM-FORMING BACTERIA | 2018-02-01 |
| 20180030048 | COMPOUNDS AND METHODS TO SUPPRESS AUTOIMMUNE RESPONSE | 2018-02-01 |
| 20180030049 | PREPARATION METHOD FOR PRAZIQUANTEL AND INTERMEDIATE COMPOUNDS THEREOF | 2018-02-01 |
| 20180030050 | Protein Kinase C Inhibitors and Uses Thereof | 2018-02-01 |
| 20180030051 | SOLID FORMS OF A COMPOUND MODULATING KINASES | 2018-02-01 |
| 20180030052 | USE OF TETRAMIC ACID DERIVATIVES AS NEMATICIDES | 2018-02-01 |
| 20180030053 | TETRACYCLIC PYRIDONE COMPOUNDS AS ANTIVIRALS | 2018-02-01 |
| 20180030054 | NOVEL INHIBITOR OF FLT3 KINASE AND USE THEREOF | 2018-02-01 |
| 20180030055 | 3,3-DIFLUORO-PIPERIDINE DERIVATIVES AS NR2B NMDA RECEPTOR ANTAGONISTS | 2018-02-01 |
| 20180030056 | BENZOFURANS SUBSTITUTED WITH BICYCLIC SECONDARY BENZAMIDE AS HCV INHIBITORS | 2018-02-01 |
| 20180030057 | SUBSTITUTED IMIDAZO[1,5-a]PYRAZINES AS CGRP RECEPTOR ANTAGONISTS | 2018-02-01 |
| 20180030058 | Crystal of 5-( (2-(6-amino)-9H-purin-9-yl) ethyl) amino) pentan-1-o1 | 2018-02-01 |
| 20180030059 | COELENTERAZINE ANALOGUES | 2018-02-01 |
| 20180030060 | SUBSTITUTED 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE | 2018-02-01 |
| 20180030061 | NOVEL PYRAZOLO PYRIMIDINE DERIVATIVES AND THEIR USE AS MALT1 INHBITORS | 2018-02-01 |
| 20180030063 | PRODRUGS OF FUMARATES AND THEIR USE IN TREATING VARIOUS DISEASES | 2018-02-01 |
| 20180030064 | COMPOUNDS AND COMPOSITIONS AND USES THEREOF | 2018-02-01 |
| 20180030065 | FLUORESCEIN POLYMER CONJUGATES | 2018-02-01 |
| 20180030066 | CRYSTAL FORM A OF COMPOUND AND PREPARATION METHOD THEREOF | 2018-02-01 |
| 20180030067 | CRYSTAL OF IMIDAZO-OXAZINE, PHARMACEUTICAL COMPOSITION CONTAINING SAID CRYSTAL, AND METHOD FOR PRODUCING SAID CRYSTAL | 2018-02-01 |
| 20180030068 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT IN WHICH SAME IS USED | 2018-02-01 |
| 20180030069 | THIENOTHIOPHENE - BORON (DONOR-ACCEPTOR) BASED MATERIALS FOR ORGANIC LIGHT EMITTING DIODES | 2018-02-01 |
| 20180030070 | Multivinylaminosilanes as Branching Agents for Functionalized Elastomeric Polymers | 2018-02-01 |
| 20180030071 | HYDRIDOSILAPYRROLES, HYDRIDOSILAAZAPYRROLES, THIASILACYCLOPENTANES, METHOD FOR PREPARATION THEREOF, AND REACTION PRODUCTS THEREFROM | 2018-02-01 |
| 20180030072 | HYDRIDOSILAPYRROLES, HYDRIDOSILAAZAPYRROLES, THIASILACYCLOPENTANES, METHOD FOR PREPARATION THEREOF, AND REACTION PRODUCTS THEREFROM | 2018-02-01 |
| 20180030073 | NATURAL LIPIDS CONTAINING NON-OXIDIZABLE FATTY ACIDS | 2018-02-01 |
| 20180030074 | PHOSPHONIUM COMPOUND AND PRODUCTION METHOD THEREFOR | 2018-02-01 |
| 20180030075 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS | 2018-02-01 |
| 20180030076 | Crystalline Fosaprepitant Dicyclohexylamine Salt and its Preparation | 2018-02-01 |
| 20180030077 | PROCESS FOR PREPARING HIGH-PURITY L-ARABINOSE BY USING ARABIC GUM AS RAW MATERIAL | 2018-02-01 |
| 20180030078 | A NEW QUINOLINE DERIVATIVE FOR USE IN THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS | 2018-02-01 |
| 20180030079 | Crystalline Form Of Nicotinamide Riboside | 2018-02-01 |
| 20180030080 | Phosphoramidate nucleoside prodrug for treating viral diseases and cancer, processes for their preparation and their use | 2018-02-01 |
| 20180030081 | BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTI- TUTED PURINE NUCLEOTIDES FOR HCV TREATMENT | 2018-02-01 |
| 20180030082 | BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'BETA-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTIT- UTED PURINE NUCLEOTIDES FOR HCV TREATMENT | 2018-02-01 |
| 20180030083 | DEUTERATED CHENODEOXYCHOLIC ACID DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING COMPOUND THEREOF | 2018-02-01 |
| 20180030084 | DEUTERATED BILE ACIDS | 2018-02-01 |
| 20180030085 | CRYSTAL FORM OF ABIRATERONE PROPIONATE AND PREPARATION METHOD THEREFOR | 2018-02-01 |
| 20180030086 | METHODS AND SYSTEMS FOR GENERATING, VALIDATING AND USING MONOCLONAL ANTIBODIES | 2018-02-01 |
| 20180030087 | METHOD FOR REMOVAL OF DNA | 2018-02-01 |
| 20180030088 | IBAT INHIBITORS FOR THE TREATMENT OF LIVER DISEASES | 2018-02-01 |
| 20180030089 | IBAT INHIBITORS FOR THE TREATMENT OF LIVER DISEASES | 2018-02-01 |
| 20180030090 | NON-MEMBRANE DISRUPTIVE P53 ACTIVATING STAPLED PEPTIDES | 2018-02-01 |
| 20180030091 | COLLAGEN-BINDING SYNTHETIC PEPTIDOGLYCANS FOR USE IN VASCULAR INTERVENTION | 2018-02-01 |
| 20180030092 | COMPOUNDS | 2018-02-01 |
| 20180030093 | SELF-ASSEMBLING ULTRASHORT ALIPHATIC CYCLIC PEPTIDES FOR BIOMEDICAL APPLICATIONS | 2018-02-01 |
| 20180030094 | CHEMICAL SYNTHESIS AND SCREENING OF BICYCLIC PEPTIDE LIBRARIES | 2018-02-01 |
| 20180030095 | SILSTATIN COMPOUNDS | 2018-02-01 |
| 20180030096 | RECOMBINANT AAV1, AAV5, AND AAV6 CAPSID MUTANTS AND USES THEREOF | 2018-02-01 |
| 20180030097 | EPITOPE-SUBSTITUTED VACCINE FOR USE IN IMPROVING SAFETY AND IMMUNOGENICITY AGAINST DENGUE VIRUSES | 2018-02-01 |
| 20180030098 | NOVEL EGFR BINDING PROTEINS | 2018-02-01 |
| 20180030099 | Apelin Fusion Proteins and Uses Thereof | 2018-02-01 |
| 20180030100 | NON-NATURAL SEMAPHORINS 3 AND THEIR MEDICAL USE | 2018-02-01 |
| 20180030101 | NOVEL PROTEINS SPECIFIC FOR PYOVERDINE AND PYOCHELIN | 2018-02-01 |
| 20180030102 | APPLICATION OF METRNL PROTEIN IN PREPARING HYPOLIPIDEMIC, HYPOGLYCEMIC MEDICINE | 2018-02-01 |
| 20180030103 | STABLE AMYLOID BETA MONOMERS AND OLIGOMERS | 2018-02-01 |
| 20180030104 | COMPOSITION AND METHOD FOR AFFECTING THE BINDING OF ANTIGEN-BINDING POLYPEPTIDES TO ANTIGENS | 2018-02-01 |
| 20180030105 | Therapeutic Compositions and Methods for Disorders Associated with Neuronal Degeneration | 2018-02-01 |
| 20180030106 | INTERLEUKIN-2 EXPRESSION CONSTRUCT USING HUMAN SERIUM ALBUMIN | 2018-02-01 |
| 20180030107 | Pharmaceutical Preparation Comprising Recombinant HcG | 2018-02-01 |
| 20180030108 | NOVEL VOLTAGE-DEPENDENT ION CHANNEL FUSIONS AND METHOD OF USE THEREOF | 2018-02-01 |
| 20180030109 | TUMOR TARGETED TNF-RELATED APOPTOSIS INDUCING LIGAND FUSION POLYPEPTIDE, METHODS AND USES THEREFOR | 2018-02-01 |
| 20180030110 | Fully-human T-cell receptor specific for the 369-377 epitope derived from the Her2/Neu (ERBB2) receptor protein. | 2018-02-01 |
| 20180030111 | FC MUTANTS WITH MODIFIED FUNCTIONAL ACTIVITY | 2018-02-01 |
| 20180030112 | NOVEL MINOR HISTOCOMPATIBILITY ANTIGENS AND USES THEREOF | 2018-02-01 |
| 20180030113 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS | 2018-02-01 |
| 20180030114 | GPR156 Variants And Uses Thereof | 2018-02-01 |
| 20180030115 | COLLAGEN MIMICS | 2018-02-01 |
| 20180030116 | VARIANTS OF TISSUE INHIBITOR OR METALLOPROTIENASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS | 2018-02-01 |
| 20180030117 | Synthetic Single Domain Antibody | 2018-02-01 |
| 20180030118 | HUMANZIED FILOVIRUS ANTIBODIES AND USES THEREOF | 2018-02-01 |
| 20180030119 | HUMAN MONOCLONAL ANTIBODY SPECIFIC FOR THE F PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS (RSV) | 2018-02-01 |
| 20180030120 | ANTI-SALMONELLA ANTIBODIES AND USES THEREOF | 2018-02-01 |
| 20180030121 | ANTIBODIES, VARIABLE DOMAINS & CHAINS TAILORED FOR HUMAN USE | 2018-02-01 |
| 20180030122 | BIOMARKERS FOR RHEUMATOID ARTHRITIS | 2018-02-01 |
| 20180030123 | METHOD FOR TREATING A TUMOR WITH BIFUNCTIONAL AGENTS THAT BIND TO TUMOR CARBOHYDRATE ANTIGENS | 2018-02-01 |
| 20180030124 | METHODS AND COMPOSITIONS FOR ENHANCING ANTI-SSEA4 IMMUNOTHERAPY | 2018-02-01 |
| 20180030125 | DEVICE AND METHOD FOR DETECTING A TARGET ANALYTE | 2018-02-01 |
| 20180030126 | IMMUNOREGULATORY STRUCTURES FROM NORMALLY OCCURING PROTEINS | 2018-02-01 |
| 20180030127 | ANTI-SERUM ALBUMIN FAB-EFFECTOR MOIETY FUSION CONSTRUCT, AND METHOD OF PREPARING THE CONSTRUCT | 2018-02-01 |
| 20180030128 | TREATMENT OF CANCER WITH ANTI-LAP MONOCLONAL ANTIBODIES | 2018-02-01 |
| 20180030129 | STEM CELL FACTOR INHIBITOR | 2018-02-01 |
| 20180030130 | METHOD OF TREATING A LOCALIZED FIBROTIC DISORDER USING AN IL-33 ANTAGONIST | 2018-02-01 |
| 20180030131 | Use of Reslizumab to Treat Moderate to Severe Eosinophilic Asthma | 2018-02-01 |
| 20180030132 | METHODS OF TREATMENT USING AN INTERFERON GAMMA INHIBITOR | 2018-02-01 |
| 20180030133 | COMPOSITIONS AND METHODS FOR TREATING FATTY TISSUE BUILDUP | 2018-02-01 |
| 20180030134 | INHIBITORS OF T-CELL ACTIVATION | 2018-02-01 |
| 20180030135 | HUMAN MONOCLONAL ANTIBODIES AGAINST OREXIN RECEPTOR TYPE 1 | 2018-02-01 |
